Spontaneous coronary artery dissection screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
*[[Cervical carotid arteries]] | *[[Cervical carotid arteries]] | ||
*Peripheral arteries of the upper and lower extremities | *Peripheral arteries of the upper and lower extremities | ||
===Screening Questions=== | |||
AHA scientific statement recommended a list of questions to rule out SCAD-associated vasculopathy and [[connective tissue disorders]]: <ref name="HayesKim2018">{{cite journal|last1=Hayes|first1=Sharonne N.|last2=Kim|first2=Esther S.H.|last3=Saw|first3=Jacqueline|last4=Adlam|first4=David|last5=Arslanian-Engoren|first5=Cynthia|last6=Economy|first6=Katherine E.|last7=Ganesh|first7=Santhi K.|last8=Gulati|first8=Rajiv|last9=Lindsay|first9=Mark E.|last10=Mieres|first10=Jennifer H.|last11=Naderi|first11=Sahar|last12=Shah|first12=Svati|last13=Thaler|first13=David E.|last14=Tweet|first14=Marysia S.|last15=Wood|first15=Malissa J.|title=Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association|journal=Circulation|volume=137|issue=19|year=2018|issn=0009-7322|doi=10.1161/CIR.0000000000000564}}</ref> | |||
{{familytree/start |summary=Sample 10}}{{familytree/start |summary=PE diagnosis Algorithm.}} | |||
{{Family tree/start}} | |||
{{familytree | | | | | B01 | | | | | B01=<div style="float: left; text-align: left;"> '''Screening Questions:'''<br> | |||
---- | |||
❑ a <br> ❑ b <br> ❑ c <br> ❑ d <br> ❑ e </div>}} | |||
{{familytree | | | | | |!| | | | | |}} | |||
{{familytree | | | | | C01 | | | | | C01=<div style="float: left; text-align: left;"> '''The Factors:'''<br> | |||
---- | |||
❑ 1 <br> ❑ 2 <br> ❑ 3 <br> ❑ 4 <br> | |||
---- | |||
❑ 5 <br> ❑ 6 <br> ❑ 7 <br> ❑ 8 </div>}} | |||
{{Family tree/end}} | |||
===Genetic Screening of Family Members=== | ===Genetic Screening of Family Members=== | ||
* [[Genetic]] [[screening]] is recommended in first-degree family members of [[patients]] with SCAD in whom a monogenic [[vascular]] [[disease]] has been identified. <ref name="HayesKim2018">{{cite journal|last1=Hayes|first1=Sharonne N.|last2=Kim|first2=Esther S.H.|last3=Saw|first3=Jacqueline|last4=Adlam|first4=David|last5=Arslanian-Engoren|first5=Cynthia|last6=Economy|first6=Katherine E.|last7=Ganesh|first7=Santhi K.|last8=Gulati|first8=Rajiv|last9=Lindsay|first9=Mark E.|last10=Mieres|first10=Jennifer H.|last11=Naderi|first11=Sahar|last12=Shah|first12=Svati|last13=Thaler|first13=David E.|last14=Tweet|first14=Marysia S.|last15=Wood|first15=Malissa J.|title=Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association|journal=Circulation|volume=137|issue=19|year=2018|issn=0009-7322|doi=10.1161/CIR.0000000000000564}}</ref> | * [[Genetic]] [[screening]] is recommended in first-degree family members of [[patients]] with SCAD in whom a monogenic [[vascular]] [[disease]] has been identified. <ref name="HayesKim2018">{{cite journal|last1=Hayes|first1=Sharonne N.|last2=Kim|first2=Esther S.H.|last3=Saw|first3=Jacqueline|last4=Adlam|first4=David|last5=Arslanian-Engoren|first5=Cynthia|last6=Economy|first6=Katherine E.|last7=Ganesh|first7=Santhi K.|last8=Gulati|first8=Rajiv|last9=Lindsay|first9=Mark E.|last10=Mieres|first10=Jennifer H.|last11=Naderi|first11=Sahar|last12=Shah|first12=Svati|last13=Thaler|first13=David E.|last14=Tweet|first14=Marysia S.|last15=Wood|first15=Malissa J.|title=Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association|journal=Circulation|volume=137|issue=19|year=2018|issn=0009-7322|doi=10.1161/CIR.0000000000000564}}</ref> | ||
Revision as of 06:15, 27 January 2021
|
Spontaneous Coronary Artery Dissection Microchapters |
|
Differentiating Spontaneous coronary artery dissection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Type 1 Type 2A Type 2B Type 3 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nate Michalak, B.A.
Synonyms and keywords: SCAD
Overview
Screening
SCAD usually is the result of an underlying vascular or connective tissue disorders. In order to provide the best care to patients with SCAD, the scientific statement from the American Heart Association (AHA) recommended a detailed review of systems and personal and family history of SCAD-associated symptoms and conditions. [1]
In addition, AHA scientific statement recommended a complete vascular exam with palpation and auscultation of the following arteries:
- Abdominal aorta
- Cervical carotid arteries
- Peripheral arteries of the upper and lower extremities
Screening Questions
AHA scientific statement recommended a list of questions to rule out SCAD-associated vasculopathy and connective tissue disorders: [1]
Screening Questions: ❑ a ❑ b ❑ c ❑ d ❑ e | |||||||||||||||||||||||
The Factors: ❑ 1 ❑ 5 ❑ 6 ❑ 7 ❑ 8 | |||||||||||||||||||||||
Genetic Screening of Family Members
- Genetic screening is recommended in first-degree family members of patients with SCAD in whom a monogenic vascular disease has been identified. [1]
- Routine clinical or genetic screening of asymptomatic relatives of patients with SCAD is not recommended.
References
- ↑ 1.0 1.1 1.2 Hayes, Sharonne N.; Kim, Esther S.H.; Saw, Jacqueline; Adlam, David; Arslanian-Engoren, Cynthia; Economy, Katherine E.; Ganesh, Santhi K.; Gulati, Rajiv; Lindsay, Mark E.; Mieres, Jennifer H.; Naderi, Sahar; Shah, Svati; Thaler, David E.; Tweet, Marysia S.; Wood, Malissa J. (2018). "Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association". Circulation. 137 (19). doi:10.1161/CIR.0000000000000564. ISSN 0009-7322.